Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$51,836,330
+$16,285,198 QoQ
Shares Held
205,994
+26.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#354
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 61%
Shared 10%
None 29%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Savant Capital, LLC holds $304,795,936 across 15 Drug Manufacturers - General names. ABBV ranks #3 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,429 | $80,876,372 | |
| 2 | JNJ |
Johnson & Johnson
|
265,777 | $67,499,384 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
205,994 | $51,836,330 | |
| 4 | MRK |
Merck & Co., Inc.
|
220,270 | $28,304,695 | |
| 5 | NVS |
Novartis AG
|
150,968 | $23,659,704 | |
| 6 | AMGN |
Amgen Inc
|
40,234 | $14,569,536 | |
| 7 | PFE |
Pfizer Inc
|
423,589 | $10,200,023 | |
| 8 | AZN |
Astrazeneca PLC
|
35,321 | $6,697,568 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,836,330 | 205,994 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $35,551,132 | 163,461 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $37,155,215 | 162,612 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $32,510,068 | 140,408 | Shares | Sole | 2026-03-04 | |
| 2025-06-30 | $25,834,591 | 139,180 | Shares | Sole | 2026-03-04 | |
| 2025-03-31 | $25,860,215 | 123,426 | Shares | Sole | 2026-03-04 | |
| 2024-12-31 | $27,451,451 | 154,482 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $30,378,150 | 153,829 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $24,189,980 | 141,033 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $25,095,747 | 137,813 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $21,363,854 | 137,858 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $20,470,260 | 137,329 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $17,272,251 | 128,199 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $14,855,515 | 93,214 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $14,651,400 | 90,659 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,766,997 | 80,225 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $13,158,435 | 85,913 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $13,038,507 | 80,430 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $10,966,723 | 80,995 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $8,796,690 | 81,549 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,939,560 | 79,364 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $8,589,096 | 79,367 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $8,056,394 | 75,188 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $6,475,178 | 73,926 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $7,249,414 | 73,838 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $5,697,716 | 74,783 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||